Abbott Laboratories: A New Growth Story Takes Shape

Abbott Laboratories is expected to report strong growth in its medical device segment, driven by its heart failure treatment, HeartMate 3.

The company's nutrition segment is also expected to perform well, despite ongoing recalls.